Production (Stage)
CalciMedica, Inc.
CALC
$1.70
-$0.02-1.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.90% | 6.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.27% | 7.60% | |||
| Operating Income | -5.27% | -7.60% | |||
| Income Before Tax | -18.41% | 24.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.41% | 24.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.41% | 24.21% | |||
| EBIT | -5.27% | -7.60% | |||
| EBITDA | -5.26% | -7.64% | |||
| EPS Basic | -8.68% | 34.89% | |||
| Normalized Basic EPS | -8.72% | 34.89% | |||
| EPS Diluted | -9.59% | 34.89% | |||
| Normalized Diluted EPS | -8.72% | 34.89% | |||
| Average Basic Shares Outstanding | 8.96% | 16.39% | |||
| Average Diluted Shares Outstanding | 8.96% | 16.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||